-
2
-
-
0016224046
-
-
See (a) Shinozaki, H.; Konishi, S. Neuropharmacology 1974, 13, 665. (b) Evans, R.H.; Francis, A.A.; Hunt, K.; Martin, M.R.; Watkins, J.C. J. Pharm. Pharmac. 1978, 30, 364. (c) Vankatraman, S.; Boon, R.J.; Schulte, M.K.; Koerner, J.F.; Johnson, R.L. J. Med. Chem. 1994, 37, 3939.
-
(1974)
Neuropharmacology
, vol.13
, pp. 665
-
-
Shinozaki, H.1
Konishi, S.2
-
3
-
-
0017852821
-
-
See (a) Shinozaki, H.; Konishi, S. Neuropharmacology 1974, 13, 665. (b) Evans, R.H.; Francis, A.A.; Hunt, K.; Martin, M.R.; Watkins, J.C. J. Pharm. Pharmac. 1978, 30, 364. (c) Vankatraman, S.; Boon, R.J.; Schulte, M.K.; Koerner, J.F.; Johnson, R.L. J. Med. Chem. 1994, 37, 3939.
-
(1978)
J. Pharm. Pharmac.
, vol.30
, pp. 364
-
-
Evans, R.H.1
Francis, A.A.2
Hunt, K.3
Martin, M.R.4
Watkins, J.C.5
-
4
-
-
0027999970
-
-
See (a) Shinozaki, H.; Konishi, S. Neuropharmacology 1974, 13, 665. (b) Evans, R.H.; Francis, A.A.; Hunt, K.; Martin, M.R.; Watkins, J.C. J. Pharm. Pharmac. 1978, 30, 364. (c) Vankatraman, S.; Boon, R.J.; Schulte, M.K.; Koerner, J.F.; Johnson, R.L. J. Med. Chem. 1994, 37, 3939.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3939
-
-
Vankatraman, S.1
Boon, R.J.2
Schulte, M.K.3
Koerner, J.F.4
Johnson, R.L.5
-
5
-
-
0030586053
-
-
Very recently a synthesis of (S)-quisqualic acid 2 via the nucleophilic ring-opening of an optically active aziridine by 1 has been reported by Baldwin's group: Farthing, C.N.; Baldwin, J.E.; Russell, A.T.; Schofield, C.J.; Spivey, A.L. Tetrahedron Letters. 1996, 37, 5225.
-
(1996)
Tetrahedron Letters
, vol.37
, pp. 5225
-
-
Farthing, C.N.1
Baldwin, J.E.2
Russell, A.T.3
Schofield, C.J.4
Spivey, A.L.5
-
6
-
-
0025892139
-
-
Lipinski, C.A.; Fiese, E.F.; Korst, R.J. Quant. Struct.-Act. Relat. 1991, 10, 109.
-
(1991)
Quant. Struct.-Act. Relat.
, vol.10
, pp. 109
-
-
Lipinski, C.A.1
Fiese, E.F.2
Korst, R.J.3
-
7
-
-
0027295702
-
-
(a) Goldstein, S.W.; McDermott, R.E.; Gibbs, E.M.; Stevenson, R.W. J. Med. Chem. 1993, 36, 2238.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 2238
-
-
Goldstein, S.W.1
McDermott, R.E.2
Gibbs, E.M.3
Stevenson, R.W.4
-
8
-
-
85022794077
-
-
Patent WO9203425 (Pfizer)
-
(b) Patent WO9203425 (Pfizer), Chem. Abstr. 1992, 117, 26553s.
-
(1992)
Chem. Abstr.
, vol.117
-
-
-
9
-
-
1542701788
-
-
US Patent 5,480,896 (American Home Products)
-
(a) US Patent 5,480,896 (American Home Products), Chem. Abstr. 1996; 124, 232471;
-
(1996)
Chem. Abstr.
, vol.124
, pp. 232471
-
-
-
10
-
-
1542596906
-
-
US Patent 5,420,146 (American Home Products)
-
(b) US Patent 5,420,146 (American Home Products), Chem. Abstr. 1995 123, 112068.
-
(1995)
Chem. Abstr.
, vol.123
, pp. 112068
-
-
-
11
-
-
1542596904
-
-
Japanese Patent 08059638 (Yamanouchi)
-
Japanese Patent 08059638 (Yamanouchi), Chem. Abstr. 1996, 125, 10826.
-
(1996)
Chem. Abstr.
, vol.125
, pp. 10826
-
-
-
13
-
-
1542492182
-
-
note
-
Satisfactory microanalysis and spectroscopic data were obtained for all new compounds.
-
-
-
-
14
-
-
1542492183
-
-
note
-
Compound 18 has also been prepared by workers at American Home Products (reference 6a) building up the 1,2,4-oxadiazolidine-3,5-dione ring in a stepwise manner similar to that outlined in Scheme 1. The compounds prepared by the two routes have similar mps (157-8°C and 155-7°C respectively).
-
-
-
-
15
-
-
0027988554
-
-
Cantello, B.C.C.; Cawthorne, M.A.; Cottam, G.P.; Duff, P.T.; Haigh, D.; Hindley, R.M.; Lister, C.A.; Smith, S.A.; Thurlby, P.L. J. Med. Chem., 1994, 37, 3977.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3977
-
-
Cantello, B.C.C.1
Cawthorne, M.A.2
Cottam, G.P.3
Duff, P.T.4
Haigh, D.5
Hindley, R.M.6
Lister, C.A.7
Smith, S.A.8
Thurlby, P.L.9
|